Tag:
Pharmexa
Latest Headlines
Latest Headlines
Pharmexa merges with Affitech, switches to antibodies
A struggling Pharmexa and Affitech have struck a deal to merge into a new company that will focus on new antibody therapeutics. After the stock transaction is closed, Affitech shareholders will
'Strategic alternatives' loom for Pharmexa
The roiled stock market is causing some headaches at a European biotech company. Troubled by disappointing mid-stage trial data and a weak stock market, Denmark's Pharmexa is signaling that it will
